Long term efficacy of ustekinumab in Crohn's disease patients after vedolizumab failure

被引：0
|
作者：
Melotti, L. [1 ]
Dussias, N. K. [1 ]
Belluzzi, A. [1 ]
Salice, M. [1 ]
Calabrese, C. [1 ]
Rizzello, F. [1 ]
Gionchetti, P. [1 ]
机构：
[1] Univ Bologna, Dept Surg & Med Sci, Bologna, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P420
引用
收藏
页码：I408 / I408
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of retreatment with vedolizumab in patients with Crohn's disease
    Sands, B. E.
    Shafran, I.
    Farraye, F. A.
    Cheifetz, A. S.
    Abhyankar, B.
    Sankoh, S.
    Smyth, M.
    [J]. JOURNAL OF CROHNS & COLITIS, 2015, 9 : S377 - S378
  • [22] Comparison of Surgical Rates in Biologic Naive Crohn's Disease Patients on Ustekinumab and Vedolizumab
    Mohammed, Abdul
    Alchirazi, Khaled Alsabbagh
    Hamid, Osama
    Eltelbany, Ahmed
    Garg, Rajat
    Paranji, Neethi
    Gonzaga, Ernesto Robalino
    Singh, Amandeep
    Kais, Susan
    Regueiro, Miguel
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S706 - S707
  • [23] Efficacy of Vedolizumab Therapy in Patients With Perianal Crohn's Disease
    Manski, Scott
    Edirisuriya, Chelsea
    Fabrizio, Joseph
    Dioguardi, Vincent
    Gandhi, Hema K.
    Shivashankar, Raina
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S847 - S848
  • [24] Efficacy and Safety of Retreatment With Vedolizumab in Patients With Crohn's Disease
    Sands, Bruce E.
    Shafran, Ira
    Farraye, Francis A.
    Cheifetz, Adam S.
    Abhyankar, Brihad
    Sankoh, Serap
    Smyth, Michael D.
    [J]. GASTROENTEROLOGY, 2015, 148 (04) : S278 - S278
  • [25] Predictors of Ustekinumab Failure After Dose Intensification Among Patients With Crohn's Disease
    Njie, Cheikh
    Sanchit, Gupta
    Allegretti, Jessica R.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S324 - S325
  • [26] Efficacy of Ustekinumab Therapy in Patients With Perianal Crohn's Disease
    Manski, Scott
    Dioguardi, Vincent
    Weil, Blake J.
    Edirisuriya, Chelsea
    Gandhi, Hema K.
    Shivashankar, Raina
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S847 - S847
  • [27] Single Center Experience With Long-term Ustekinumab in Patients With Refractory Crohn's Disease (Prior Anti-TNF and Vedolizumab Therapy)
    Bennett, Audrey L.
    Evers, Lauren
    Duley, Caroline V.
    Annis, Kim
    Beaulieu, Dawn B.
    Adams, Dawn W.
    Schwartz, David A.
    Horst, Sara N.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S397 - S398
  • [28] Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn's disease: a multicentre retrospective study
    Cassandra, Rayer
    Nachury, Maria
    Arnaud, Bourreille
    Xavier, Roblin
    Laurent, Peyrin-Biroulet
    Stephanie, Viennot
    Mathurin, Flamant
    David, Laharie
    Benedicte, Caron
    Marie, Dewitte
    Laurent, Siproudhis
    Mathurin, Fumery
    Guillaume, Bouguen
    [J]. BMC GASTROENTEROLOGY, 2022, 22 (01)
  • [29] Efficacy of ustekinumab, vedolizumab, or a second anti-TNF agent after the failure of a first anti-TNF agent in patients with Crohn’s disease: a multicentre retrospective study
    Cassandra Rayer
    Maria Nachury
    Arnaud Bourreille
    Xavier Roblin
    Laurent Peyrin-Biroulet
    Stephanie Viennot
    Mathurin Flamant
    David Laharie
    Bénédicte Caron
    Marie Dewitte
    Laurent Siproudhis
    Mathurin Fumery
    Guillaume Bouguen
    [J]. BMC Gastroenterology, 22
  • [30] Crohn's disease: vedolizumab vs. ustekinumab after anti-TNF pretreatment
    Simon, Annika
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2023, 61 (09): : 1168 - 1170
12345